Skip to content
tecovirimat

Structure via PubChem · Public domain (PubChem)

EntityQ7692792· pop 20· linked from 103 articles

tecovirimat

Sign in to save

Also known as ST-246, Tpoxx, rel-N-[(3aR,4R,4aR,5aS,6S,6aS)-3,3a,4,4a,5,5a,6,6a-Octahydro-1,3-dioxo-4,6-ethenocycloprop[f]isoindol-2(1H)-yl]-4-(trifluoromethyl)benzamide

Tecovirimat, sold under the brand name Tpoxx among others, is an antiviral medication with activity against orthopoxviruses such as smallpox and mpox. In 2018 it was the first antipoxviral drug approved in the United States.

Chemical data

Formula
C19H15F3N2O3
Molecular weight
376.3 g/mol
IUPAC name
N-[(1R,2R,6S,7S,8S,10R)-3,5-dioxo-4-azatetracyclo[5.3.2.02,6.08,10]dodec-11-en-4-yl]-4-(trifluoromethyl)benzamide
SMILES
C1[C@@H]2[C@H]1[C@@H]3C=C[C@H]2[C@@H]4[C@H]3C(=O)N(C4=O)NC(=O)C5=CC=C(C=C5)C(F)(F)F
InChIKey
CSKDFZIMJXRJGH-VWLPUNTISA-N
XLogP
2.6
Polar surface area
66.5 Ų
H-bond donors
1
H-bond acceptors
6
Formal charge
0

via PubChem

Wikidata facts

Mass
376.103
Show 4 more facts
canonical SMILES
C1C2C1C3C=CC2C4C3C(=O)N(C4=O)NC(=O)C5=CC=C(C=C5)C(F)(F)F
chemical formula
C₁₉H₁₅F₃N₂O₃
isomeric SMILES
C1[C@@H]2[C@H]1[C@@H]3C=C[C@H]2[C@@H]4[C@H]3C(=O)N(C4=O)NC(=O)C5=CC=C(C=C5)C(F)(F)F
Commons category
Tecovirimat
Sources (2)

via Wikidata · CC0

~7 min read

Encyclopedic overview

9 sections
Contents
  • Medical uses
  • Mechanism of action
  • Chemistry
  • History
  • Clinical trials
  • Society and culture
  • Legal status
  • References
  • External links

{{Drugbox | verifiedrevid = | drug_name = | INN = | type = | image = Tecovirimat.svg | image_class = skin-invert-image | width = 200 | alt = | caption =

| pronounce = | tradename = Tpoxx | Drugs.com = | MedlinePlus = | licence_CA = | licence_EU = | DailyMedID = Tecovirimat | licence_US = | pregnancy_AU = | pregnancy_AU_comment = | pregnancy_category= | routes_of_administration = By mouth, intravenous | class = | ATCvet = | ATC_prefix = J05 | ATC_suffix = AX24 | ATC_supplemental =

Excerpted from Wikipedia’s “tecovirimat” article, available under the CC BY-SA 4.0 licence.

Gallery (2)